References
- Trinkaus J. P. On the mechanism of metazoan cell movements. The Cell Surface in Animal Embryogenesis and Development, G. Poste, G. I. Nicolson. North-Holland, Amsterdam 1976; 226–329
- Tucker G. C., Boyer B., Gavrilovic J., et al. Collagen-mediated dispersion of NBT-II rat bladder carcinoma cells. Cancer Res 1990; 50: 129–137
- Boyer B., Tucker G. C., Valles A. M., et al. Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder cells. J Cell Biol 1989; 109: 1495–1509
- Valles A. M., Boyer B., Badet, et al. Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc Natl Acad Sci (USA) 1990; 87: 1124–1128
- Friesel R., Burgess W. H., Maciag T. Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells. Mol Cell Biol 1989; 9: 1857–1865
- Gherardi E., Gray J., Stoker M., et al. Purification of scatter factor, a fibroblast derived basic protein that modulates epithelial interactions and movement. Proc. Natl Acad Sci (USA) 1989; 86: 5844–5848
- Grey A-M, Schor A. M., Rushton G., et al. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci (USA) 1989; 86: 2438–2442
- Guirguis R. J., Schifhann E., Liu E., et al. Detection of autocrine motility factor in urine as a marker of bladder cancer. Natl Cancer Inst 1988; 80: 1203–1211
- Chinkers M., McKanna J. A., Cohen S. Rapid induction of morphological changes in human carcinoma cells A-431 by epidermal growth factors. J Cell Biol 1979; 83: 260–265
- Stracke M. L., Engel J. D., Wilson L. W., et al. The type I IGF receptor is a motility receptor in human melanoma cells. J Biol Cell 1989; 264: 21544–21549
- Tamm I., Cardinale I., Krueger J., et al. Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med, 170: 1649–1670
- Chodak G. W., Hospelhorn V., Judge S. M., et al. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder and kidney cancer. Cancer Res 1988; 48: 2083–2088